Lisa A Uebelacker1,2, Risa B Weisberg2,3, Debra S Herman1,2, Genie L Bailey2,4, Megan M Pinkston-Camp2,5, Michael D Stein1,2,5. 1. Butler Hospital, Providence, Rhode Island. 2. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, Rhode Island. 3. Boston VA Healthcare System, Boston, Massachusetts. 4. Stanley Street Treatment and Resources, Fall River, Massachusetts. 5. The Immunology Center, The Miriam Hospital, Providence, Rhode Island, USA.
Abstract
OBJECTIVE: As the advent of highly active antiretroviral therapy, HIV has become a chronic disease for most individuals in developed countries. Chronic pain is a common occurrence for HIV-infected patients and has an impact on quality of life and antiretroviral adherence. The objective of this study was to examine relationships between chronic pain and depression, substance use, mental health treatment, and pain treatment in HIV-infected patients. DESIGN: Cross-sectional study. SETTING: Three primary care sites where HIV+ patients receive treatment. SUBJECTS: Two hundred and thirty eight HIV-infected primary care patients. METHODS: We collected self-report and chart-review information on demographics, HIV clinical status, chronic pain, depression, substance use, mental health treatment, and pain treatment. We collected data between October 2012 and November 2013. RESULTS: Of the patients enrolled in this study, 107 reported no chronic pain, 24 reported mild chronic pain, and 107 reported moderate-severe chronic pain. Participants in the moderate-severe pain group were more likely to have high levels of depressive symptoms than those in the no chronic pain group. Similarly, there was a significant relationship between chronic pain status and interference with life activities due to pain. Participants with moderate-severe chronic pain were more likely to be taking an antidepressant medication than those with mild chronic pain, and more likely to be taking a prescription opioid than the other two groups. We did not find a significant relationship between problematic substance use and chronic pain status. CONCLUSIONS: Despite pharmacologic treatment, moderate-severe chronic pain and elevated depression symptoms are common among HIV-infected patients and frequently co-occur. Wiley Periodicals, Inc.
OBJECTIVE: As the advent of highly active antiretroviral therapy, HIV has become a chronic disease for most individuals in developed countries. Chronic pain is a common occurrence for HIV-infectedpatients and has an impact on quality of life and antiretroviral adherence. The objective of this study was to examine relationships between chronic pain and depression, substance use, mental health treatment, and pain treatment in HIV-infectedpatients. DESIGN: Cross-sectional study. SETTING: Three primary care sites where HIV+ patients receive treatment. SUBJECTS: Two hundred and thirty eight HIV-infected primary care patients. METHODS: We collected self-report and chart-review information on demographics, HIV clinical status, chronic pain, depression, substance use, mental health treatment, and pain treatment. We collected data between October 2012 and November 2013. RESULTS: Of the patients enrolled in this study, 107 reported no chronic pain, 24 reported mild chronic pain, and 107 reported moderate-severe chronic pain. Participants in the moderate-severe pain group were more likely to have high levels of depressive symptoms than those in the no chronic pain group. Similarly, there was a significant relationship between chronic pain status and interference with life activities due to pain. Participants with moderate-severe chronic pain were more likely to be taking an antidepressant medication than those with mild chronic pain, and more likely to be taking a prescription opioid than the other two groups. We did not find a significant relationship between problematic substance use and chronic pain status. CONCLUSIONS: Despite pharmacologic treatment, moderate-severe chronic pain and elevated depression symptoms are common among HIV-infectedpatients and frequently co-occur. Wiley Periodicals, Inc.
Authors: M Melloh; A Elfering; C Egli Presland; C Röder; P Hendrick; B Darlow; J-C Theis Journal: Occup Med (Lond) Date: 2011-01-03 Impact factor: 1.611
Authors: Nur F Önen; Ernie-Paul Barrette; Enbal Shacham; Toshibumi Taniguchi; Michael Donovan; Edgar T Overton Journal: Pain Pract Date: 2011-11-22 Impact factor: 3.183
Authors: Bradley E Aouizerat; Christine A Miaskowski; Caryl Gay; Carmen J Portillo; Traci Coggins; Harvey Davis; Clive R Pullinger; Kathryn A Lee Journal: J Assoc Nurses AIDS Care Date: 2010-01-29 Impact factor: 1.354
Authors: Hilary L Surratt; Steven P Kurtz; Maria A Levi-Minzi; Theodore J Cicero; Kiyomi Tsuyuki; Catherine L O'Grady Journal: AIDS Patient Care STDS Date: 2014-07-01 Impact factor: 5.078
Authors: Laurence Brunet; Sonia Napravnik; Amy D Heine; Peter A Leone; Joseph J Eron Journal: J Acquir Immune Defic Syndr Date: 2017-05-01 Impact factor: 3.731
Authors: Samuel F Freedman; Carrie Johnston; John J Faragon; Eugenia L Siegler; Tessa Del Carmen Journal: Eur Geriatr Med Date: 2018-12-06 Impact factor: 1.710
Authors: Andrea H Weinberger; Elizabeth K Seng; Joseph W Ditre; Melody Willoughby; Jonathan Shuter Journal: Nicotine Tob Res Date: 2019-03-30 Impact factor: 4.244
Authors: Sara D Pullen; Christi Acker; Haemi Kim; Morgan Mullins; Payton Sims; Holly Strasbaugh; Samantha Zimmerman; Carlos Del Rio; Vincent C Marconi Journal: AIDS Res Hum Retroviruses Date: 2020-06-02 Impact factor: 2.205
Authors: Maile Y Karris; Jeff Berko; Peter D Mazonson; Theoren M Loo; Frank Spinelli; Andrew Zolopa Journal: AIDS Res Hum Retroviruses Date: 2020-07-08 Impact factor: 2.205